Clinical Trials · NCT05247268
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Fudan University
- Enrollment
- 104
- Start date
- Mar 2022
- Locations
- 1 site, China
- Primary endpoint
- Complete response rates within 16 weeks of treatment